knowledge
Previous article:
FDA approval of Sarepta Duchenne genetic therapy gives me hope
Next article: A ‘polypill’ could sharply reduce cardiovascular disease in the U.S.
Next article: A ‘polypill’ could sharply reduce cardiovascular disease in the U.S.
leisure time
focus
-
PhRMA lawsuit over Medicare drug price negotiation tossed
2025-10-02 00:17 -
KalVista pill reduced swelling 'attacks' caused by genetic disease
2025-10-01 23:58 -
Faced with fears of OxyContin misuse, sales reps touted its safety
2025-10-01 23:56 -
Maui funeral service workers on devastation of fires: 'I'm in shock'
2025-10-01 23:01 -
Genentech weighs delaying cancer therapy after drug pricing law
2025-10-01 22:28 -
A ‘polypill’ could sharply reduce cardiovascular disease in the U.S.
2025-10-01 22:18